Valid for Submission
C34.81 is a billable code used to specify a medical diagnosis of malignant neoplasm of overlapping sites of right bronchus and lung. The code is valid for the year 2020 for the submission of HIPAA-covered transactions.
ICD-10: | C34.81 |
Short Description: | Malignant neoplasm of ovrlp sites of right bronchus and lung |
Long Description: | Malignant neoplasm of overlapping sites of right bronchus and lung |
Diagnostic Related Groups
The ICD-10 code C34.81 is grouped in the following groups for version MS-DRG V37.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2020 through 09/30/2020.
- 180 - RESPIRATORY NEOPLASMS WITH MCC
- 181 - RESPIRATORY NEOPLASMS WITH CC
- 182 - RESPIRATORY NEOPLASMS WITHOUT CC/MCC
Convert C34.81 to ICD-9
- 162.8 - Mal neo bronch/lung NEC (Approximate Flag)
Code Classification
Code History
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
(First year ICD-10-CM implemented into the HIPAA code set) - FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020